Skip to main content
Log in

Quality-of-Life Measures as Providers of Information on Value-for-Money of Health Interventions

Comparison and Recommendations for Practice

  • Review Article
  • Quality of Life and Value-for-Money
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Abstract

Summary

Three different approaches to measuring quality of life have been developed. Global scales (e.g. time trade-off, visual analogue), multi-attribute utility scales and multidimensional scales (which may be generic or disease-specific). Each of these approaches to measurement provides different kinds of information about quality of life and each can be used to provide information to healthcare purchasers concerning the relative value-for-money of health interventions.

The value-for-money of health interventions, in terms of quality of life, can be demonstrated in 2 ways: a formula-driven approach based on cost-utility analysis, which uses scales generating the unit of a quality-adjusted life-year (i.e. global and multi-attribute utility): and a non-formula-driven approach, which uses scales generating multidimensional profiles of quality of life (i.e. multi-attribute utility and multidimensional).

Analysis shows that no single approach is sufficient, and that healthcare purchasers should use a variety of types of information in their decision-making, including both cost-utility and informal approaches. Healthcare resource allocation is inevitably a value-dependent activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Tengs TO, Adams ME, Pliskin JS, et al. Five hundred life-saving interventions and their cost-effectiveness. Risk Anal 1995; 15: 369–90

    Article  PubMed  CAS  Google Scholar 

  2. Torrance Gw. Measurement of health state utilities for economic appraisal. J Health Econ 1986; 5: 1–30

    Article  PubMed  CAS  Google Scholar 

  3. Torrance GW, Sackett DL, Thomas WH. A utility maximization model for evaluation of health care programs. Health Serv Res 1972; 7: 118–33

    PubMed  CAS  Google Scholar 

  4. O’Brien B, Viramontes JL. Willingness-to-pay — a valid and reliable measure of health state preference. Med Decis Making 1994; 14: 289–97

    Article  PubMed  Google Scholar 

  5. Wagenaar WA. Paradoxes of gambling behaviour. Hillsdale: Earlbaum, 1988

    Google Scholar 

  6. Tsevat J, Goldman L, Lamas GA, et al. Functional status versus utilities in survivors of myocardial infarction. Med Care 1991; 29: 1153–9

    Article  PubMed  CAS  Google Scholar 

  7. Skavem K. Quality of life in epilepsy: comparison of four utility measures. Qual Life Res 1995; 4: 489–90

    Google Scholar 

  8. Hyland ME, Sodergren Sc. Development of a new type of global quality of life scale, and comparison of performance and preference for 12 global scales. Qual Life Res 1996; 5: 469–80

    Article  PubMed  CAS  Google Scholar 

  9. Borg G. A category scale with ratio properties for intermodal and interindividual comparisons. In: Geissler HG, Petzold P, editors. Psychological judgement and the process of perception. Berlin: VEB Deutscher Verlag der Vissenschaften. 1982: 25–34

    Google Scholar 

  10. Bergner M, Bobbit RA, Carter WB, et al. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981; 19: 787–805

    Article  PubMed  CAS  Google Scholar 

  11. Kaplan RM, Bush JW. Health-related quality of life measurement for evaluation of research and policy analysis. Health Psychol 1982; 1: 61–80

    Article  Google Scholar 

  12. EuroQol Group. EuroQol — a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199–208

    Article  Google Scholar 

  13. Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36). Med Care 1992; 30: 473–83

    Article  PubMed  Google Scholar 

  14. Hyland ME. A reformulation of quality of life for medical science. Qual Life Res 1991; 1: 267–72

    Article  Google Scholar 

  15. Hyland ME. The items in quality of life scales: how item selection creates bias and how bias can be prevented. Pharmacoeconomics 1992; 1: 1112–90

    Article  Google Scholar 

  16. Rutten-van Molken MPMH, Custers F, Van Doorslaer EKA, et al. Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life. Eur Respir J 1995; 8: 888–98

    Google Scholar 

  17. Hyland ME. Antiasthma drugs: quality of life rating scales and sensitivity to longitudinal change. Pharmacoeconomics 1994; 6: 324–9

    PubMed  CAS  Google Scholar 

  18. Hyland ME, Ley A, Fisher DW, et al. Measurement of psychological distress in asthma and asthma management programs. Br J Clin Psychol 1995; 34: 601–11

    Article  PubMed  Google Scholar 

  19. O’Boyle C. Quality of life in palliative care — seeing the trees. In: Ford G, Lewin I, editors. Managing terminal illness. London: Royal College of Physicians, 1996: 37–50

    Google Scholar 

  20. Kind P. Weighting life expectancy for quality: whose values count? Qual Life Res 1995; 4: 447–8

    Google Scholar 

  21. Patrick DL, Peach H, Gregg I. Disablement and care: a comparison of patient views and general practitioner knowledge. J Royal Coil Gen Pract 1982; 32: 429–34

    CAS  Google Scholar 

  22. Hyland ME. Health and value: the values underlying health measurement and health resource allocation. Psychol Health. In press

  23. Evans JStB. Bias in human reasoning: causes and consequences. Hillsdale: Earlbaum, 1989

    Google Scholar 

  24. Donaldson C. Formulate don’t formularise. BMJ 1994; 308: 906

    Article  Google Scholar 

  25. Hadorn DC. Setting health care priorities in Oregon: cost effectiveness meets the rule of rescue. JAMA 1991; 256: 2218–25

    Article  Google Scholar 

  26. Hyland ME, Crocker GR. Validation of an asthma quality of life diary in a clinical trial. Thorax 1995; 50: 724–30

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hyland, M.E. Quality-of-Life Measures as Providers of Information on Value-for-Money of Health Interventions. Pharmacoeconomics 11, 19–31 (1997). https://doi.org/10.2165/00019053-199711010-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199711010-00004

Keywords

Navigation